VEDANTRA PHARMACEUTICALS INC has a total of 13 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2015. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are G&P BIOSCIENCE CO LTD, DECIBEL THERAPEUTICS INC and ISA PHARMACEUTICALS B V.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Canada | 2 | |
#4 | United States | 2 | |
#5 | Australia | 1 | |
#6 | China | 1 | |
#7 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Therapeutic chemical compounds | |
#5 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Demuth Peter C | 12 |
#2 | Eby Jackson | 12 |
#3 | Li Adrienne | 12 |
Publication | Filing date | Title |
---|---|---|
CA3012764A1 | Alk polypeptides and methods of use thereof | |
EP3244927A1 | Multilamellar lipid vesicle compositions including a conjugated anaplastic lymphoma kinase (alk) variant and uses thereof | |
AU2015314763A1 | Multilamellar lipid vesicle compositions and methods of use |